Navigation Links
New Ovarian Cancer Biomarker Research Act Introduced
Date:10/2/2007

Funding, Research and National Trials Crucial in the Fight Against Women's

Cancers

WASHINGTON, Oct. 2 /PRNewswire-USNewswire/ -- The Ovarian Cancer Biomarker Research Act of 2007 was introduced in the U.S. House of Representatives on Thursday, Sept. 27 and the Society of Gynecologic Oncologists (SGO), the leader of four organizations integral in drafting this legislation, is issuing a "call to action" for ovarian cancer survivors, their families, and their physicians.

Introduced by Congressmen Howard L. Berman (D-CA) and Ralph M. Hall (D-TX), the Ovarian Cancer Biomarker Research Act would authorize the National Cancer Institute (NCI) to make grants to public or non-profit entities for the establishment of research centers focused on ovarian cancer biomarkers. Biomarkers are the biochemical features within the body that can be used to determine the presence and population of cancerous cells, predict response to therapy, and determine ultimate prognosis. Additionally, the Ovarian Cancer Biomarker Research Act will also establish a national clinical trial to determine the clinical utility of ovarian cancer biomarkers in diagnosing or preventing ovarian cancer in at-risk women.

SGO, which is the professional organization for gynecologic oncologists, specialists in women's cancers, collaborated with the American College of Obstetricians and Gynecologists (ACOG), the Ovarian Cancer National Alliance, and the American College of Surgeons (ACS) to spearhead the development of the Ovarian Cancer Biomarker Research Act in order to secure dedicated support for ovarian cancer biomarkers research. Currently, a widely accepted or effective screening test for ovarian cancer is not available -- making the disease difficult to diagnose.

"Early diagnosis is critical," said Beth Karlan, MD, Director of the Cedars-Sinai Women's Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute and an expert in the field of gynecologic oncology, ovarian cancer surgery, and inherited cancer susceptibility. "Women have just recently been made aware of the symptoms of ovarian cancer, but many of these symptoms can be easily confused with those of other diseases. Development of an effective biomarker screening test is imperative to saving the lives of women with ovarian cancer."

"What we need now is wide-spread action," adds Carol Brown, MD, a gynecologic oncologist at Memorial Sloan-Kettering Cancer Center and SGO's Government Relations Committee Chair. "The bill has been introduced, but it hasn't been passed yet. We are so appreciative that the Ovarian Cancer Biomarker Research Act has come this far, and we are grateful for the help and support we have received from Congressmen Berman and Hall, but we need to make sure that that this bill is passed. We need every woman, every family, every physician to contact their Congressmen and express their support for the Ovarian Cancer Biomarkers Research Act. It is quite literally -- and quite unfortunately -- a matter of life and death."

Adds Lindy Graham, an ovarian cancer survivor and advocate, "We absolutely need to pass this bill so our daughters, sisters, mothers, friends and neighborhood of women will finally be able to obtain early ovarian cancer detection that will ultimately save lives. No more sneak attacks from this disease!"

About SGO

The Society of Gynecologic Oncologists (SGO) is a national medical specialty society for physicians trained in the comprehensive management of women's cancers. The Society's membership is primarily comprised of gynecologic oncologists -- obstetrician/gynecologists who undertake an additional 3-4 years of intensive training in the specific study of gynecologic cancers. SGO members provide medical and surgical care to women with ovarian cancer, cervical cancer, endometrial cancer, vulvar cancer, and vaginal cancer. They are trained to in chemotherapy and radiation therapy administration, supportive care, and surgery in order to provide comprehensive care to their patients. More information on gynecologic oncology, the SGO, and its members can be found at http://www.sgo.org.

Contact: Jessica Schackmuth

Cell: (312) 235-4060


'/>"/>
SOURCE Society of Gynecologic Oncologists
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Ovarian cancer in relationship with Hormone therapy
2. Vitamin D Reduces Chances of Colon, Breast And Ovarian Cancers by 50%
3. Progestin protects against ovarian cancer
4. Inherited gene important in ovarian cancer
5. Blood test may identify ovarian cancer
6. Exercise lowers Risk of Ovarian Cancer
7. Screening device for ovarian cancer
8. Ethnic discrepancy in ovarian cancer
9. Associated scan for detecting ovarian cancer spread
10. Gene Mutation Causes Ovarian Failure
11. Ovarian Cancer Screening Questioned
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Consumers have ... and regulators/payers have placed more emphasis on patient ... patient support programs in the pharmaceutical industry have ... medications. Consequently, pharmaceutical companies are focusing on becoming ... are providing products and services that improve health. ...
(Date:6/24/2016)... 2016   Bay Area Lyme Foundation , ... Center for Tick Borne Illness , Harvard Medical ... Hacking Medicine, University of California, Berkeley, and the ... five finalists of Lyme Innovation , the ... 100 scientists, clinicians, researchers, entrepreneurs, and investors from ...
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
Breaking Medicine Technology: